These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21940055)

  • 1. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
    Knippenberg S; Peelen E; Smolders J; Thewissen M; Menheere P; Cohen Tervaert JW; Hupperts R; Damoiseaux J
    J Neuroimmunol; 2011 Oct; 239(1-2):80-6. PubMed ID: 21940055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
    Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
    Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
    Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
    J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
    Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
    Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.
    Todd SK; Pepper RJ; Draibe J; Tanna A; Pusey CD; Mauri C; Salama AD
    Rheumatology (Oxford); 2014 Sep; 53(9):1693-703. PubMed ID: 24729396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
    Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
    Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional alterations of regulatory B cell subsets in adult allergic asthma patients.
    Wiest M; Upchurch K; Hasan MM; Cardenas J; Lanier B; Millard M; Turner J; Oh S; Joo H
    Clin Exp Allergy; 2019 Sep; 49(9):1214-1224. PubMed ID: 31132180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
    Lisak RP; Benjamins JA; Nedelkoska L; Barger JL; Ragheb S; Fan B; Ouamara N; Johnson TA; Rajasekharan S; Bar-Or A
    J Neuroimmunol; 2012 May; 246(1-2):85-95. PubMed ID: 22458983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis.
    Tørring C; Petersen CC; Bjerg L; Kofod-Olsen E; Petersen T; Höllsberg P
    J Neuroimmunol; 2013 Sep; 262(1-2):92-9. PubMed ID: 23856341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
    Bartosińska J; Purkot J; Karczmarczyk A; Chojnacki M; Zaleska J; Własiuk P; Grząśko N; Morawska M; Walter-Croneck A; Usnarska-Zubkiewicz L; Zielińska P; Jamroziak K; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.
    Lundqvist S; Modvig S; Fischer EA; Frederiksen JL; Degn M
    Immunology; 2019 Mar; 156(3):259-269. PubMed ID: 30452090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes.
    Liu Y; Chen Z; Qiu J; Chen H; Zhou Z
    Front Immunol; 2021; 12():773896. PubMed ID: 35754999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
    Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M
    Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
    Blumenfeld S; Staun-Ram E; Miller A
    J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory and naïve B-cell subsets in patients with multiple sclerosis.
    Niino M; Hirotani M; Miyazaki Y; Sasaki H
    Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of Vitamin D in multiple sclerosis.
    Correale J; Ysrraelit MC; Gaitán MI
    Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.
    Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Rheumatology (Oxford); 2016 Feb; 55(2):263-7. PubMed ID: 26350483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
    Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
    J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.